Advertisement

Author: Carly Behm

A spine biologics company's $100 million investment deal and six more key updates in regenerative medicine in the last two months:

Advertisement

Spineart USA's Baguera C cervical disc prosthesis has marked its 100th surgery in combined single-level and two-level U.S. investigational device exemption clinical trials.

Advertisement